Skip to main content
. 2020 Apr 14;21(8):2709. doi: 10.3390/ijms21082709

Figure 1.

Figure 1

Strategies targeting high mobility group box 1 (HMGB1)-mediated brain damage after an aneurysmal subarachnoid hemorrhage (aSAH). Summary of the pharmacological strategies to block HMGB1 in SAH. Blocking HMGB1 with multiple agents reduced cerebral vasospasm and brain damage after SAH.